Amtech to Acquire Controlling Interest in Ion Implant Technology Company Based in China
Amtech Systems, Inc. (NASDAQ: ASYS) today announced it has entered into an agreement to acquire a controlling interest in a China-based ion implant technology company located in Shanghai, China.
The acquisition is expected to close in February 2011, subject to compliance with formal Hong Kong filing requirements.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.